Treatment costs to come down for 30 diseases in Dubai
DHA to introduce value-based ‘Ejadah’ across predominant diseases by 2025
Patients with about 30 predominant diseases will receive quality care and insurance approvals that would cut treatment costs in Dubai under Dubai Health Authority’s (DHA) health care model called ‘Ejadah’.
The DHA announced yesterday at Arab Health 2023 that it will introduce the model across 30 disease areas for the emirate by 2025. Ejadah, which means proficiency in Arabic, was launched in June 2022.
DHA’s Dubai Health Insurance Corporation, which regulates the health insurance sector in Dubai, is overseeing the implementation of Ejadah.
AI for early intervention
Saleh Al Hashimi, CEO of Dubai Health Insurance Corporation, said: “The model will create a transformational shift in the health sector as providers and payers move towards a value-based care model instead of the current volume-based care model.” The value-based health care model will pay for performance and outcomes that matter to patients.
The model uses Artificial Intelligence (AI) technology for predictive health care analysis for early intervention, disease prevention and to prevent complications caused by the disease. The AI technology will be initially used for two diseases: diabetes and asthma.
This year, the focus will be on: chronic obstructive pulmonary disease (COPD), Inflammatory bowel disease (IBD), Osteoporosis, Hyper/Hypothyroidism, Atopic dermatitis, Urinary Tract Infections, Migraine and Myocardial Infarction (MI).
Areas of focus
In 2024, the focus will be on: Peptic Ulcer Disease, Rheumatoid Arthritis, Obesity and Metabolic Syndrome, Polycystic Ovarian Syndrome, Acne, Benign Prostatic Hyperplasia and Arrhythmia.
In 2025, the areas of focus will include: Gallstones, Osteoporosis, Thyroid disease, Dermatitis, Psoriasis, CHD/Stroke, DVT and renal failure.